Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase Inhibitors

[Image: see text] Mutations in the human leucine rich repeat protein kinase-2 (LRRK2) create risk factors for Parkinson’s disease, and pathological functions of LRRK2 are often correlated with aberrant kinase activity. Past research has focused on developing selective LRRK2 kinase inhibitors. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Jui-Hung, Ma, Wen, Wu, Jian, Sharma, Pallavi Kaila, Silletti, Steve, McCammon, J. Andrew, Taylor, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127209/
https://www.ncbi.nlm.nih.gov/pubmed/37043829
http://dx.doi.org/10.1021/acschembio.2c00868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127209/
https://www.ncbi.nlm.nih.gov/pubmed/37043829
http://dx.doi.org/10.1021/acschembio.2c00868

Ejemplares similares